Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.14
-0.07 (-0.49%)
Mar 31, 2025, 1:32 PM EDT - Market open
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of $11.15 billion as of March 31, 2025. Its market cap has decreased by -11.07% in one year.
Market Cap
11.15B
Enterprise Value
11.09B
1-Year Change
-11.07%
Ranking
Category
Stock Price
$13.14
Market Cap Chart
Since April 11, 2001, Dr. Reddy's Laboratories's market cap has increased from $839.80M to $11.15B, an increase of 1,227.30%. That is a compound annual growth rate of 11.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 11.01B | -16.40% |
Dec 31, 2024 | 13.17B | 13.66% |
Dec 29, 2023 | 11.59B | 34.54% |
Dec 30, 2022 | 8.61B | -20.82% |
Dec 31, 2021 | 10.88B | -8.18% |
Dec 31, 2020 | 11.85B | 75.79% |
Dec 31, 2019 | 6.74B | 7.74% |
Dec 31, 2018 | 6.25B | 0.47% |
Dec 29, 2017 | 6.23B | -19.41% |
Dec 30, 2016 | 7.73B | -2.05% |
Dec 31, 2015 | 7.89B | -8.10% |
Dec 31, 2014 | 8.58B | 23.16% |
Dec 31, 2013 | 6.97B | 23.45% |
Dec 31, 2012 | 5.64B | 13.32% |
Dec 30, 2011 | 4.98B | -20.18% |
Dec 31, 2010 | 6.24B | 53.01% |
Dec 31, 2009 | 4.08B | 147.47% |
Dec 31, 2008 | 1.65B | -45.95% |
Dec 31, 2007 | 3.05B | 9.23% |
Dec 29, 2006 | 2.79B | 68.91% |
Dec 30, 2005 | 1.65B | 8.92% |
Dec 31, 2004 | 1.52B | -37.34% |
Dec 31, 2003 | 2.42B | 50.67% |
Dec 31, 2002 | 1.61B | 2.01% |
Dec 31, 2001 | 1.58B | 87.63% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 730.71B |
UnitedHealth Group | 477.72B |
Johnson & Johnson | 398.56B |
AbbVie | 366.68B |
Novo Nordisk | 305.46B |
Abbott Laboratories | 228.32B |
AstraZeneca | 225.46B |
Merck & Co. | 225.15B |